Empowering the Patient Voice: Genomic Testing and Cancer Care Decisions

Video Library —January 7, 2022

Categories:

Genetics & Genomics
Frank dela Rama, RN, MS, AOCNS
Clinical Nurse Specialist
Oncology/Genomics
Sutter Palo Alto Foundation
Sara Campbell, BS, BSN, OCN
Associate Director
Medical Science Liaisons
Exact Sciences
Jim G.
Oncotype DX® Genomic Prostate Score Patient

In this roundtable discussion presented by AONN+ and supported by Exact Sciences, a panel of experts discuss the critical role of nurse navigators in educating cancer patients about genomic testing and how to interpret the results. Topics include:

  • Genomic versus genetic testing – What’s the difference?
  • Benefits of genomic testing across different cancer types
  • The role of nurse navigators in educating cancer patients about genomic testing

Presented by AONN+

Supported by  Exact Sciences

Related Articles
Keynote: Genetic Therapies Will Explode, Better Access to Data Will Drive Value
June 2022 Vol 13, No 6
Over the past 5 years, there have been 20 FDA approvals of novel genetic medicine technologies – and this is just the beginning. Here’s a glimpse of what’s coming ahead.
AONN+ 2020 CEU Monograph: Early Detection, Vaping, Fertility Preservation, and Genetic Testing
Meg Barbor, MPH
|
December 2020 Vol 11, No 12
Proceedings from key sessions from an AONN+ conference are presented in this CEU activity.
Direct-to-Consumer Genetic Testing: What Patients and Providers Should Know
September 2020 Vol 11, No 9
Navigators can meet the ever-growing needs of patients undergoing genetic testing. Here’s how.
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
SUBSCRIBE

Contact Us | Editorial Board

© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512